|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-6-15
|
|
pubmed:abstractText |
To assess the incremental cost-effectiveness ratio (ICER) of glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) pretreated with aspirin and clopidogrel undergoing an early invasive treatment strategy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1524-4733
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
853-61
|
|
pubmed:meshHeading |
pubmed-meshheading:18489507-Acute Coronary Syndrome,
pubmed-meshheading:18489507-Aged,
pubmed-meshheading:18489507-Aspirin,
pubmed-meshheading:18489507-Confidence Intervals,
pubmed-meshheading:18489507-Cost-Benefit Analysis,
pubmed-meshheading:18489507-Drug Therapy, Combination,
pubmed-meshheading:18489507-Female,
pubmed-meshheading:18489507-Humans,
pubmed-meshheading:18489507-Male,
pubmed-meshheading:18489507-Markov Chains,
pubmed-meshheading:18489507-Models, Economic,
pubmed-meshheading:18489507-Platelet Aggregation Inhibitors,
pubmed-meshheading:18489507-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:18489507-Quality-Adjusted Life Years,
pubmed-meshheading:18489507-Risk,
pubmed-meshheading:18489507-Risk Assessment,
pubmed-meshheading:18489507-Spain,
pubmed-meshheading:18489507-Ticlopidine
|
|
pubmed:articleTitle |
Using triple antiplatelet therapy in patients with non-ST elevation acute coronary syndrome managed invasively: a cost-effectiveness analysis.
|
|
pubmed:affiliation |
Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain. jlatour@wanadoo.es
|
|
pubmed:publicationType |
Journal Article
|
